ARCHIVES

NCI Issues Statement On Endostatin Research

This article is from The Cancer Letter archive.

Vol. 25 No. 37 | October 1, 1999

Download PDF Visit The Full Archive

Related Articles

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013